Rare diseases
Investigational molecules
Locations
Effingerstrasse 33, 3008
Research activity includes diffuse large B-cell lymphoma, with attention to molecularly defined subgroups, PET/CT response, and circulating tumour DNA as markers used to guide treatment intensity.
The sponsor also supports studies in testicular germ cell tumours, including seminoma, with interest in adapting radio-chemotherapy to disease extent.
Swiss Group for Clinical Cancer Research runs clinical trials in conditions such as Hormone-refractory prostate cancer, Triple negative breast cancer, Adult T-cell lymphoma/leukaemia, Testicular seminoma (pure) stage II, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Spain
France
Italy
GermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
